Relationship between systemic immune-inflammation index and depression among individuals with and without
Dan Liu1, Chaojie He2, Xinguo Luo3
1Department of Clinical Psychology, The First Hospital of Jiaxing University, Jiaxing, 314000, China.
Insights
The systemic immune-inflammation index (SII) is linked to a higher risk of depressive symptoms, especially in those without cardiovascular disease (CVD). This suggests SII may help predict depression risk in the general population.
Area of Science:
- Cardiovascular Medicine
- Psychiatry
- Immunology
Background:
- Depression frequently co-occurs with cardiovascular disease (CVD), with both conditions linked to chronic inflammation.
- The systemic immune-inflammation index (SII) is a marker of systemic inflammation, but its association with depressive symptoms in CVD patients is unclear.
Purpose of the Study:
- To investigate the association between SII and depressive symptoms in individuals with and without CVD.
- To determine if SII can serve as a predictor for depressive symptoms.
Main Methods:
- Utilized cross-sectional data from 29,479 participants in the National Health and Nutrition Examination Survey (NHANES) 2005-2016.
- Assessed depressive symptoms using the Patient's Health Questionnaire (PHQ-9).
- Calculated SII (platelet count × neutrophil count/lymphocyte count) and analyzed associations using logistic regression and smooth curve fitting.
Main Results:
- A higher SII was significantly associated with increased depressive symptoms in the overall population (OR: 1.101).
- The association was stronger in individuals without CVD (OR: 1.121) compared to those with CVD (OR: 1.055).
- Participants in the highest SII tertile showed a significantly higher risk of depressive symptoms, particularly in the non-CVD group (OR: 1.161).
Conclusions:
- The SII is independently associated with an increased risk of depressive symptoms, most notably in individuals without CVD.
- SII may be a valuable predictor for depressive symptoms in the general population, aiding early screening and intervention.
- Further research is needed to understand the underlying mechanisms and clinical utility of SII in assessing depressive symptoms, particularly concerning cardiovascular health.
Objective:
Depression is a common comorbidity in cardiovascular disease (CVD), and both conditions are associated with chronic inflammation. The systemic immune-inflammation index (SII) has emerged as a promising marker of systemic inflammation, but its role in association with depressive symptoms, particularly in the context of CVD, remains unclear. This study aims to investigate the association of SII with depressive symptoms in individuals with and without CVD using cross-sectional data from NHANES (2005-2016).
Methods:
A total of 29,479 participants from the National Health and Nutrition Examination Survey (NHANES) 2005-2016 waves were included. Depressive symptoms were assessed through Patient's Health Questionnaire (PHQ-9). SII was calculated as the platelet count × neutrophil count/lymphocyte count. In order to determine the relationships between SII and depressive symptoms in participants with and without CVD, binary logistic regression model and smooth curve fitting were used. We also performed sensitivity analyses and subgroup analysis.
Results:
The total prevalence of depressive symptoms was 8.73% among the 29,479 participants analyzed. After adjusting for confounding factors, a higher SII was significantly associated with increased depressive symptoms in the total population (OR per SD increase: 1.101, 95% CI: 1.060-1.144, P < 0.0001). This association was stronger in participants without CVD (OR: 1.121, 95% CI: 1.073-1.172, P < 0.0001) compared to those with CVD (OR: 1.055, 95% CI: 0.973-1.144, P = 0.19571). Participants in the highest SII tertile had a significantly higher risk of depressive symptoms compared to those in the lowest tertile, particularly in the non-CVD group (OR: 1.161, 95% CI: 1.026-1.313, P = 0.01765).
Conclusion:
The SII is independently associated with an increased risk of depressive symptoms, particularly in individuals without CVD. These findings suggest that the SII may serve as a valuable predictor of depressive symptoms in the general population, with potential implications for early screening and intervention strategies. Further research is needed to elucidate the mechanisms underlying this association and to explore the clinical utility of SII in depressive symptoms assessment, especially in the context of cardiovascular health.
More Related Videos
Related Concept Videos
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:30Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
01:27Depressive Disorders: MDD and Dysthymia
01:18Depression: Overview